ent outcomes and has been
referred to by several industry sources as the gold standard in pulse
oximetry. In 2005, Masimo introduced Masimo Rainbow SET Pulse CO-Oximetry,
which, for the first time, noninvasively monitors the level of carbon
monoxide and methemoglobin in the blood, allowing early detection and
treatment of potentially life-threatening conditions. Founded in 1989,
Masimo has the mission of "Improving Patient Outcomes and Reducing Cost of
Care by Taking Noninvasive Monitoring to New Sites and Applications."
Additional information about Masimo and its products may be found at
http://www.masimo.com.
Forward Looking Statements
This press release may include forward-looking statements. These
forward-looking statements are based on current expectations about future
events affecting us and are subject to uncertainties and factors, all of
which are difficult to predict and many of which are beyond our control,
including: risks related to our assumption that the Masimo Rad-57 Pulse
CO-Oximeter will deliver a sufficient level of clinical improvement over
alternative devices to allow for rapid adoption of the technology, and
other factors discussed in the "Risk Factors" section of our quarterly
report on Form 10-Q for the quarter ended September 29, 2007, filed with
the Securities and Exchange Commission on November 1, 2007. Although we
believe that the expectations reflected in our forward-looking statements
are reasonable, we do not know whether our expectations will prove correct.
You are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date hereof. We do not undertake any
obligation to update, amend or clarify these forward-looking statements or
the risk factors contained in our quarterly report on Form 10-Q for the
quarter ended September 29, 2007, whether as a result of new information,
future events or otherwise, except as may be required u
'/>"/>
SOURCE Masimo Corporation Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 Related biology technology :1.
Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference2.
The Government of Quebec and the New Canadian Government Invest in the Creation of an International Biobank3.
International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers4.
Arrow International Files and Mails Definitive Proxy Materials5.
Niceware International Announces Licensed Vendor Status with ICCBBA, Inc. to Provide ISBT 128-compliant Software6.
DuPont, Genencor International and Tate & Lyle Honored for Groundbreaking Work in Developing Bio-PDO(TM)7.
Viragen International to Reverse Split Its Common Stock8.
Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products9.
Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products10.
PAREXEL International to Present at Thomas Weisel Partners Healthcare Conference11.
Biosafety and Biosecurity International Conference 2007 to be held in Abu Dhabi from November 12 to 14